160 related articles for article (PubMed ID: 37494875)
1. Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1/FXR signaling in bile duct ligation-induced liver fibrosis.
Qin T; Hasnat M; Wang Z; Hassan HM; Zhou Y; Yuan Z; Zhang W
Phytomedicine; 2023 Sep; 118():154971. PubMed ID: 37494875
[TBL] [Abstract][Full Text] [Related]
2. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
3. Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.
Feng S; Xie X; Li J; Xu X; Chen C; Zou G; Lin G; Huang T; Hu R; Ran T; Han L; Zhang Q; Li Y; Zhao X
Hepatol Int; 2024 Jun; 18(3):1040-1052. PubMed ID: 38172440
[TBL] [Abstract][Full Text] [Related]
4. Using Network Pharmacology for Systematic Understanding of Geniposide in Ameliorating Inflammatory Responses in Colitis Through Suppression of NLRP3 Inflammasome in Macrophage by AMPK/Sirt1 Dependent Signaling.
Pu Z; Liu Y; Li C; Xu M; Xie H; Zhao J
Am J Chin Med; 2020; 48(7):1693-1713. PubMed ID: 33202149
[TBL] [Abstract][Full Text] [Related]
5. Gpbar-1/cAMP/PKA signaling mitigates macrophage-mediated acute cholestatic liver injury via antagonizing NLRP3-ASC inflammasome.
Zhuang L; Jia N; Zhang L; Zhang Q; Antwi SO; Sartorius K; Wu K; Sun D; Xi D; Lu Y
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167266. PubMed ID: 38806072
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
7. Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
Niu WX; Bao YY; Zhang N; Lu ZN; Ge MX; Li YM; Li Y; Chen MH; He HW
Bioorg Chem; 2022 Oct; 127():105971. PubMed ID: 35749855
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1.
Ning ZW; Luo XY; Wang GZ; Li Y; Pan MX; Yang RQ; Ling XG; Huang S; Ma XX; Jin SY; Wang D; Li X
Antioxid Redox Signal; 2017 Jul; 27(1):1-20. PubMed ID: 27502441
[TBL] [Abstract][Full Text] [Related]
9. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
Qu J; Yuan Z; Wang G; Wang X; Li K
Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
[TBL] [Abstract][Full Text] [Related]
10. Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α.
Zhu L; Wang L; Cao F; Liu P; Bao H; Yan Y; Dong X; Wang D; Wang Z; Gong P
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):195-205. PubMed ID: 29360226
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.
Hao H; Cao L; Jiang C; Che Y; Zhang S; Takahashi S; Wang G; Gonzalez FJ
Cell Metab; 2017 Apr; 25(4):856-867.e5. PubMed ID: 28380377
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury.
Frissen M; Liao L; Schneider KM; Djudjaj S; Haybaeck J; Wree A; Rolle-Kampczyk U; von Bergen M; Latz E; Boor P; Trautwein C
Hepatology; 2021 May; 73(5):1836-1854. PubMed ID: 32748971
[TBL] [Abstract][Full Text] [Related]
13. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.
Blokker BA; Maijo M; Echeandia M; Galduroz M; Patterson AM; Ten A; Philo M; Schungel R; Gutierrez-de Juan V; Halilbasic E; Fuchs C; Le Gall G; Milkiewicz M; Milkiewicz P; Banales JM; Rushbrook SM; Mato JM; Trauner M; Müller M; Martínez-Chantar ML; Varela-Rey M; Beraza N
Hepatology; 2019 Feb; 69(2):699-716. PubMed ID: 30229970
[TBL] [Abstract][Full Text] [Related]
14. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution.
Adjei-Mosi J; Sun Q; Smithson SB; Shealy GL; Amerineni KD; Liang Z; Chen H; Wang M; Ping Q; Han J; Morita M; Kamat A; Musi N; Zang M
Aging Cell; 2023 May; 22(5):e13811. PubMed ID: 36999514
[TBL] [Abstract][Full Text] [Related]
16. TUDCA Ameliorates Liver Injury Via Activation of SIRT1-FXR Signaling in a Rat Hemorrhagic Shock Model.
Sun S; Zhao B; Qi M; Yao Y; Xu L; Ji R; Chen W; Wang J; Huang S; Ma L; Chen Y; Yang Z; Sheng H; Fei J; Chen E; Mao E
Shock; 2020 Feb; 53(2):217-222. PubMed ID: 30998645
[TBL] [Abstract][Full Text] [Related]
17. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
Zhang LL; Huang S; Ma XX; Zhang WY; Wang D; Jin SY; Zhang YP; Li Y; Li X
Free Radic Biol Med; 2016 Aug; 97():531-543. PubMed ID: 27445100
[TBL] [Abstract][Full Text] [Related]
19. FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury.
Han CY; Rho HS; Kim A; Kim TH; Jang K; Jun DW; Kim JW; Kim B; Kim SG
Cell Rep; 2018 Sep; 24(11):2985-2999. PubMed ID: 30208322
[TBL] [Abstract][Full Text] [Related]
20. Gardenia extract protects against intrahepatic cholestasis by regulating bile acid enterohepatic circulation.
Qin S; Tian J; Zhao Y; Wang L; Wang J; Liu S; Meng J; Wang F; Liu C; Han J; Pan C; Zhang Y; Yi Y; Li C; Liu M; Liang A
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117083. PubMed ID: 37634748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
